A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications

Journal of Clinical Investigation

Volumn 100, Issue 2, 1997, Pages 404-410

  Chung, Daniel C ^a   Smith, Alison P ^a   Louis, David N ^a   Graeme Cook, Fiona ^a   Warshaw, Andrew L ^a   Arnold, Andrew ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chromosome 3p25; Islet cell tumor; Pancreatic endocrine tumor; Tumor suppressor gene; VHL gene

Indexed keywords

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER GENETICS; CANCER SURGERY; CHROMOSOME 3P; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; ENDOCRINE TUMOR; FEMALE; GENE LOCUS; GENE LOSS; HUMAN; HUMAN TISSUE; MALE; MALIGNANT NEOPLASTIC DISEASE; PANCREAS TUMOR; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

EID: 0030748590     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119547     Document Type: Article

References (50)

1. Kloppel, G., P.A. In't Veld, B. Stamm, and P.U. Heitz. 1991. The endocrine pancreas. In Functional Endocrine Pathology. K. Kovacs and S.L. Asa, editors. Blackwell Scientific Publications, Boston. 396.
2. Jen, J., H. Kim, S. Piantadosi, Z.-F. Liu, R.C. Levitt, P. Sistonen, K.W. Kinzler, B. Vogelstein, and S.R. Hamilton. 1994. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N. Engl. J. Med. 331:213-221.
3. Caron, H., P. van Sluis, J. de Kraker, J. Bokkerink, M. Egeler, G. Laureys, R. Slater, A. Westerveld, P.A. Voute, and R. Versteeg. 1996. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N. Engl. J. Med. 334:225-230.
4. Yashiro, T., N. Fulton, H. Hara, K. Yasuda, A. Montag, N. Yashiro, F. Straus, K. Ito, Y. Aiyoshi, and E. Kaplan. 1993. Comparison of mutations of ras oncogene in human pancreatic exocrine and endocrine tumors. Surgery (St. Louis). 114:758-764.
5. Evers, B.M., P.L. Rady, K. Sandoval, I. Arany, S.K. Tyring, R.L. Sanchez, W.H. Nealon, C.M. Townsend, and J.C. Thompson. 1994. Gastrinomas demonstrate amplification of the HER-2/neu proto-oncogene. Ann. Surg. 219:596-604.
6. Pavelic, K., R. Hrascan, S. Kapitanovic, N. Karapandza, Z. Vranes, M. Belicza, B. Kruslin, and T. Cabrijan. 1995. Multiple genetic alterations in malignant metastatic insulinomas. J. Pathol. 177:395-400.
7. Yoshimoto, K., H. Iwahana, A. Fukuda, T. Sano, S. Saito, and M. Itakura. 1992. Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction-single strand conformation polymorphism. Cancer Res. 52:5061-5064.
8. Eubanks, P.J., M.P. Sawicki, G.J. Samara, R. Gatti, Y. Nakamura, D. Tsao, C. Johnson, M. Hurwitz, Y.-Y. Wan, and E. Passaro. 1994. Putative tumor-suppressor gene on chromosome 11 is important in sporadic endocrine tumor formation. Am. J. Surg. 167:180-185.
9. Latif, F., K. Tory, J. Gnarra, M. Yao, F.-M. Duh, M. Orcutt, T. Stackhouse, I. Kuzmin, W. Modi, L. Geil, et al. 1993. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science (Wash. DC). 260:1317-1320.
10. Duan, D.R., A. Pause, W.H. Burgess, T. Aso, D.Y.T. Chen, K.P. Garrett, R.C. Conaway, J.W. Conaway, W.M. Linehan, and R.D. Klausner. 1995. Inhibition of transcription elongation by the VHL tumor suppressor protein. Science (Wash. DC). 269:1402-1406.
11. Crossey, P.A., K. Foster, F.M. Richards, M.E. Phipps, F. Latif, K. Tory, M.H. Jones, E. Bentley, R. Kumar, M.I. Lerman, et al. 1994. Molecular genetic investigations of the mechanism of tumorigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumors. Hum. Genet. 93:53-58.
12. Gnarra, J., K. Tory, Y. Weng, L. Schmidt, M. Wei, H. Li, F. Latif, S. Liu, F. Chen, F.-M. Duh, et al. 1994. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat. Genet. 7:85-90.
13. Crossey, P.A., F.M. Richards, K. Foster, J.S. Green, A. Prowse, F. Latif, M.I. Lerman, B. Zbar, N.A. Affara, M.A. Ferguson-Smith, and E.R. Maher. 1994. Identification of intragenic mutations in the von Hippel-Lindau disease tumor suppressor gene and correlation with disease phenotype. Hum. Mol. Genet. 3:1303-1308.
14. Whaley, J.M., J. Naglich, L. Gelbert, Y.E. Hsia, J.M. Lamiell, J.S. Green, D. Collins, H.P.H. Neumann, J. Laidlaw, F.P. Li, et al. 1994. Germ-line mutations in the von Hippel-Lindau tumor suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am. J. Hum. Genet. 55:1092-1102.
15. Kanno, H., K. Kondo, S. Ito, I. Yamamoto, S. Fujii, S. Torigoe, N. Sakai, M. Hosaka, T. Shuin, and M. Yao. 1994. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res. 54:4845-4847.
16. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 9.16-9.19.
17. Wright, D.K., and M.M. Manos. 1990. Sample preparation from paraffin-embedded tissues. In PCR Protocols: A Guide to Methods and Applications. M.A. Innis, D.H. Gelfand, J.J. Sninsky, and T.J. White, editors. Academic Press, Inc., San Diego, CA. 153-158.
18. Kloppel, G., H. Holler, and P.U. Heitz. 1993. Pancreatic endocrine tumors in man. In Diagnostic Histopathology of Neuroendocrine Tumors. J.M. Polak, editor. Churchill Livingstone, Edinburgh. 91-121.
19. Cryns, V.L., S.M. Yi, H. Tahara, R.D. Gaz, and A. Arnold. 1995. Frequent loss of chromosome arm 1p DNA in parathyroid adenomas. Genes Chromosomes Cancer. 13:9-17.
20. Arnold, A., C.E. Staunton, H.G. Kim, R.D. Gaz, and H.M. Kronenberg. 1988. Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N. Engl. J. Med. 318:658-662.
21. Ganly, P.S., and P.H. Rabbitts. 1991. Polymerase chain reaction (PCR) for detection of Hind III polymorphism at the D3F15S2 locus. Nucleic Acids Res. 19:3758.
22. Sekido, Y., S. Bader, F. Latif, J.R. Gnarra, A.F. Gazdar, W.M. Linehan, B. Zbar, M.I. Lerman, and J.D. Minna. 1994. Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines. Oncogene. 9:1599-1604.
23. Kok, K., J. Osinga, B. Carritt, M.B. Davis, A.H. van der Hout, A.Y. van der Veen, R.M. Landsvater, L.F.M.H. de Leij, H.H. Berendsen, P.E. Postmus, et al. 1987. Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature (Lond.). 330:578-581.
24. Killary, A.M., M.E. Wolf, T.A. Giambernardi, and S.L. Naylor. 1992. Definition of a tumor suppressor locus within human chromosome 3p21-22. Proc. Natl. Acad. Sci. USA. 89:10877-10881.
25. Naylor, S.L., B.E. Johnson, J.D. Minna, and A.Y. Sakaguchi. 1987. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature (Lond.). 329:451-154.
26. van den Berg, A., M.M.F. Hulsbeek, D. de Jong, K. Kok, P.M.J.F. Veldhuis, V.J. Roche, and C.H.C.M. Buys. 1996. Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis. Genes Chromosomes Cancer. 15:64-72.
27. Powell, S.M., N. Zilz, Y. Beazer-Barclay, T.M. Bryan, S.R. Hamilton, S.N. Thibodeau, B. Vogelstein, and K.W. Kinzler. 1992. APC mutations occur early during colorectal tumorigenesis. Nature (Lond.). 359:235-237.
28. Linehan, W.M., M.I. Lerman, and B. Zbar. 1995. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer. JAMA (J. Am. Med. Assoc.). 273:564-570.
29. Herman, J.G., F. Latif, Y. Weng, M.I. Lerman, B. Zbar, S. Liu, D. Samid, D.-S.R. Duan, J.R. Gnarra, W.M. Linehan, and S.B. Baylin. 1994. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA. 91:9700-9704.
30. Chen, F., T. Kishida, M. Yao, T. Hustad, D. Glavac, M. Dean, J.M. Gnarra, M.L. Orcutt, F.M. Duh, G. Glenn, et al. 1995. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum. Mutat. 5:66-75.
31. Levine, A.J., M.C. Wu, A. Chang, A. Silver, E.F. Attiyeh, J. Lin, and C.B. Epstein. 1995. The spectrum of mutations at the p53 locus. Evidence for tissue-specific mutagenesis, selection of mutant alleles, and a gain of function phenotype. Ann. NY Acad. Sci. 768:111-128.
32. Kamb, A., N. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S. Tavtigian, E. Stockert, R. Day, B. Johnson, and M. Skolnick, 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Wash. DC). 264:436-440.
33. Tavtigian, S.V., J. Simard, J. Rommens, F. Couch, D. Shattuck-Eidens, S. Neuhausen, S. Merajver, S. Thorlacius, K. Offit, D. Stoppa-Lyonnet, et al. 1996. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat. Genet. 12:333-337.
34. Shimizu, T., J. Toguchida, M. Kato, A. Kaneko, K. Ishizaki, and M. Sasaki. 1994. Detection of mutations of the RB1 gene in retinoblastoma patients by using exon-by-exon PCR-SSCP analysis. Am. J. Hum. Genet. 54:793-800.
35. Zeiger, M.A., B. Zbar, H. Keiser, W.M. Linehan, and J.R. Gnarra. 1995. Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von Hippel-Lindau disease-associated, and familial pheochromocytoma. Genes Chromosomes Cancer. 13:151-156.
36. Daly, M.C., R.-H. Xiang, D. Buchhagen, C.H. Hensel, D.K. Garcia, A.M. Killary, J.D. Minna, and S.L. Naylor. 1993. A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity. Oncogene. 8:1721-1729.
37. Waber, P.G., N.K. Lee, and P.D. Nisen. 1996. Frequent allelic loss at chromosome arm 3p is distinct from genetic alterations of the Von-Hippel Lindau tumor suppressor gene in head and neck cancer. Oncogene. 12:365-369.
38. Roz, L., C.L. Wu, S. Porter, C. Scully, P. Speight, A. Read, P. Sloan, and N. Thakker. 1996. Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis. Cancer Res. 56:1228-1231.
39. Rowley, H., A. Jones, D. Spandidos, and J. Field. 1996. Definition of a tumor suppressor gene locus on the short arm of chromosome 3 in squamous cell carcinoma of the head and neck by means of microsatellite markers. Arch. Otolaryngol. Head Neck Surg. 122:497-501.
40. Fukui, H., K. Fujimoto, H. Mizuguchi, K. Sakamoto, Y. Horio, S. Takai, K. Yamada, and S. Ito. 1994. Molecular cloning of the human histamine H1 receptor gene. Biochem. Biophys. Res. Commun. 201:894-901.
41. Michelini, S., M. Urbanek, M. Dean, and D. Goldman. 1995. Polymorphism and genetic mapping of the human oxytocin receptor gene on chromosome 3. Am. J. Med. Genet. 60:183-187.
42. Legerski, R.J., P. Liu, L. Li, C.A. Peterson, Y. Zhao, R.J. Leach, S.L. Naylor, and M.J. Siciliano. 1994. Assignment of xeroderma pigmentosum group C (XPC) gene to chromosome 3p25. Genomics. 21:266-269.
43. Isobe, M., Y. Kumura, Y. Murata, S. Takaki, A. Tominaga, K. Takatsu, and Z. Ogita. 1992. Localization of the gene encoding the alpha subunit of human interleukin-5 receptor (IL5RA) to chromosome region 3p24-3p26. Genomics. 14:755-758.
44. Collins, F.S. 1995. Positional cloning moves from perditional to traditional. Nat. Genet. 9:347-350.
45. Heitz, P.U., M. Kasper, G. Kloppel, J.M. Polak, and J.L. Vaitukaitis. 1983. Glycoprotein-hormone alpha-chain production by pancreatic endocrine tumors: a specific marker for malignancy. Cancer. 51:277-282.
46. Graeme-Cook, F., G. Nardi, and C.C. Compton. 1990. Immunocytochemical staining for human chorionic gonadotropin subunits does not predict malignancy in insulinomas. Am. J. Clin. Pathol. 93:273-276.
47. Bordi, C., F.P. Pilato, and T. D'Adda. 1988. Comparative study of seven neuroendocrine markers in pancreatic endocrine tumors. Virchows Arch. Abt. A Pathol. Anal. 413:387-398.
48. Crossey, P., E. Maher, M. Jones, F. Richards, F. Latif, M. Phipps, M. Lush, K. Foster, K. Tory, J. Green, et al. 1993. Genetic linkage between Von Hippel-Lindau disease and three microsatellite polymorphisms refines the localisation of the VHL locus. Hum. Mol. Genet. 2:279-282.
49. Naylor, S.L., S. Moore, U. Garcia, X. Xiang, X. Xin, M. Mohrer, B. Reus, R. Linn, V. Stanton, P. O'Connell, and R. Leach. 1996. Mapping 638 STSs to regions of human chromosome 3. Cytogenet. Cell Genet. 72:90-94.
50. Naylor, S., B. Carritt, C. Boileau, C. Beroud, C. Alexander, P. Allderdice, A. Alimov, T. Ashworth, J. Bonifas, P. Bugert, et al. 1996. Report of the sixth international workshop on human chromosome 3 mapping 1995. Cytogenet. Cell Genet. 72:255-270.